<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS205621</article-id><article-id pub-id-type="doi">10.1101/2025.05.14.654095</article-id><article-id pub-id-type="archive">PPR1022328</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>In-Vivo Evidence For Increased Tau Deposition In Temporal Lobe Epilepsy</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Cruces</surname><given-names>Raúl R.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lam</surname><given-names>Jack</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Arafat</surname><given-names>Thaera</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Royer</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Judy</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sahlas</surname><given-names>Ella</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dascal</surname><given-names>Arielle</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pana</surname><given-names>Raluca</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hopewell</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hsiao</surname><given-names>Chris Hung-Hsin</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Massarweh</surname><given-names>Gassan</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Soucy</surname><given-names>Jean-Paul</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Villeneuve</surname><given-names>Sylvia</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Caciagli</surname><given-names>Lorenzo</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Koepp</surname><given-names>Matthias J.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bernasconi</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bernasconi</surname><given-names>Neda</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Bernhardt</surname><given-names>Boris C.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>McConnell Brain Imaging Centre, Montreal Neurological Institute, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap>, <city>Montreal</city>, <state>Québec</state>, <country country="CA">Canada</country></aff><aff id="A2"><label>2</label>Montreal Neurological Institute, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cpxjv19</institution-id><institution>McGill University Health Centre (MUHC)</institution></institution-wrap> and other <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap></aff><aff id="A3"><label>3</label>StoP-AD Centre, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dk2r620</institution-id><institution>Douglas Mental Health University Institute</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap>, <city>Montréal</city>, <state>QC</state>, <country country="CA">Canada</country></aff><aff id="A4"><label>4</label>UCL Queen Square Institute of Neurology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap>, <city>London</city><postal-code>WC1N 3BG</postal-code>, <country country="GB">UK</country></aff><aff id="A5"><label>5</label>Department of Neurology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q9sj412</institution-id><institution>Inselspital</institution></institution-wrap>, Sleep-Wake-Epilepsy Center, Bern University Hospital, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02k7v4d05</institution-id><institution>University of Bern</institution></institution-wrap>, <city>Bern</city>, <country country="CH">Switzerland</country></aff><author-notes><corresp id="CR1">
<bold>Corresponding author</bold> Raul Cruces, PhD, <email>raul.rodriguez-cruces@mcgill.ca</email>; Boris C. Bernhardt, PhD, <email>boris.bernhardt@mcgill.ca</email>
</corresp><fn id="FN1"><label>*</label><p id="P1">joint senior authors</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>19</day><month>05</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>18</day><month>05</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P2">Temporal lobe epilepsy (TLE), the most common pharmaco-resistant epilepsy in adults, has been linked to structural brain changes extending beyond the mesiotemporal areas. While not traditionally viewed as a neurodegenerative disorder, recent <italic>ex-vivo</italic> studies have shown elevated levels of misfolded tau protein in TLE. This study investigated tau deposition in TLE patients using the <italic>in-vivo</italic> PET tracer [18F]MK-6240. 18 TLE patients and 20 healthy controls underwent PET imaging, with data analyzed to assess tau uptake and its relationship with brain connectivity, clinical variables, and cognitive function. Compared to controls, TLE patients exhibited markedly increased [18F]MK-6240 uptake in bilateral superior and medial temporal regions and the parietal cortex, with tau accumulation following regional functional and structural connectivity, disease duration, and cognitive impairment. These findings suggest that tau accumulation may contribute to the progression of TLE and cognitive decline, supporting a potential role of tau in epilepsy-related neurodegeneration.</p></abstract><kwd-group><kwd>Temporal lobe epilepsy</kwd><kwd>[<sup>18</sup>F]MK-6240</kwd><kwd>tauopathy</kwd><kwd>neuroimaging</kwd><kwd>neuroinflammation</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">Mounting evidence suggests that temporal lobe epilepsy (TLE), the most common pharmaco-resistant epilepsy in adults, is not a static condition, but one that is associated with progressive changes extending beyond the mesiotemporal disease epicenter <sup><xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R4">4</xref></sup>. Although the exact causes of disease progression remain unknown, several lines of evidence suggest similar mechanisms as in Alzheimer’s disease (AD), an established neurodegenerative condition. First, cognitive profiles in middle-aged pharmaco-resistant epilepsy patients resemble those of mild cognitive impairment, which can be linked to AD <sup><xref ref-type="bibr" rid="R5">5</xref></sup>. Furthermore, epidemiological studies have indicated an elevated risk for pharmaco-resistant epilepsy patients to be diagnosed with AD, and <italic>vice versa</italic> <sup><italic>6</italic>,<italic>7</italic></sup>. Across all age groups, patients with AD show a 3-fold higher risk of suffering from epilepsy <sup><xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R9">9</xref></sup>. Finally, an analysis of <italic>ex-vivo</italic> specimens in operated TLE patients has shown highly elevated levels of misfolded tau protein in operated TLE patients <sup><xref ref-type="bibr" rid="R10">10</xref></sup>, a hallmark of AD pathology<sup><xref ref-type="bibr" rid="R11">11</xref></sup>. Such findings complement data from animal models of TLE, which demonstrate that seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways <sup><xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref></sup>.</p><p id="P4">Whole-brain patterns remain unknown due to limits imposed by the scope of resection. Also, while <italic>ex-vivo</italic> tau increases in TLE were related to postoperative cognitive decline <sup><xref ref-type="bibr" rid="R14">14</xref></sup>, correlations with measures of preoperative cognitive function remain incompletely understood. These considerations underscore the need for <italic>in-vivo</italic> analyses of tau in TLE to evaluate its potential role as both a modulator of cognitive function and a predictor of clinical outcomes. Research in AD and other neurodegenerative conditions has benefitted from the introduction of second-generation PET tracers that are sensitive and specific to pathological deposits. In particular, the [<sup><xref ref-type="bibr" rid="R18">18</xref></sup>F]-MK-6240 tracer (<italic>henceforth</italic> MK-6240) has shown high affinity and selectivity to intracellular neurofibrillary tangles <sup><xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R17">17</xref></sup>. In contrast, while there is an extensive PET literature in epilepsy on presurgical localization of hypometabolism via [<sup><xref ref-type="bibr" rid="R18">18</xref></sup>F]fluorodeoxyglucose <sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup>, PET studies in epilepsy have so far not systematically investigated tau tracers<sup><xref ref-type="bibr" rid="R7">7</xref></sup>. As such the whole brain distribution of tau in epileptic patients remains unknown. Unlike research in AD, where tau uptake patterns are increasingly understood and contextualized with respect to patterns of brain connectivity, there have not been any systematic assessments of potential network-level effects underlying the accumulation of these pathological deposits in TLE.</p><p id="P5">The objective of our study was to investigate the distribution and prevalence of tau aggregates in TLE using <italic>in-vivo</italic> MK-6240 PET. Tau mapping was complemented with network decoding models informed by multimodal MRI investigations in the same participants that tested for spatial associations of tau uptake in patients with patterns of global and local connectivity. Moreover, linear models examined associations with cognitive function assessed outside the scanner and clinical measures from the patients presurgical examination.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Widespread increases in tau uptake in TLE</title><p id="P6">Global mean MK-6240 SUVR was increased in patients with TLE relative to controls, both ipsilateral (t=2.36, p=0.02) and contralateral (t=2.75, p=0.008) to the seizure focus.</p><p id="P7">Surface-wide MK-6240 SUVR findings indicated high uptake in patients relative to controls in superior-posterior temporal and parietal cortex (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Statistical comparisons based on mixed-effects models confirmed significant increases in MK-6240 SUVR between patients and controls (p<sub>FWE</sub>&lt;0.025, <xref ref-type="fig" rid="F1">Figure 1B</xref>), with strongest effects localized to the ipsilateral frontal operculum and the posterior cortex, including the anterior and inferior parietal lobe (postcental, supramarginal and angular gyrus) and the lateral temporal (superior temporal gyrus) and occipital cortices. In the contralateral hemisphere, a similar pattern was observed, sparing the occipital region, but with a larger involvement of the temporal lobe, encompassing the posterior section of the superior and middle temporal gyri, and the premotor cortex. In significant clusters, we did not observe inter-hemispheric differences in overall effects (ipsilateral: t=5.02, p&lt;0.001; contralateral: t=4.92, p&lt;0.001).</p><p id="P8">These group-wise findings were complemented with individualized MK-6240 SUVR histogram analysis across the cortical surface (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Here, 75% of TLE patients but no controls demonstrated elevated mean SUVR above 1.5 (95th percentile), with a spatial distribution generally resembling the statistical effects. This pattern was more pronounced in the ipsilateral hemisphere but showed a similar bilateral distribution (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>). To assess whether MK-6240 increases were seen even after correcting for grey matter atrophy, a common feature in TLE <sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>, we re-ran the mixed effects model controlling vertex-wise for regional grey matter thickness estimates and our results were largely unaffected (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2</xref>).</p><p id="P9">Longitudinal data were available in a subset of our cohort (10/7 patients and 7 controls) with a minimum follow up time of 12 months (median=15 months, range=12-36 months). Although there was a numerically higher increase in MK-6240 SUVR in patients with TLE (0.0184 SUVR/year) relative to controls (0.0161 SUVR/year), this effect did not reach statistical significance (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3</xref>).</p></sec><sec id="S4"><title>Association to network architecture</title><p id="P10">We assessed the overall susceptibility of globally highly interconnected regions to tauopathy using network decoding models (<xref ref-type="fig" rid="F2">Figure 2</xref>) This analysis revealed a marginal increase in MK-6240 SUVR in highly connected regions defined by functional connectivity (r=0.38, p<sub>spin</sub>=0.1), while associations with structurally connected hubs were weaker and not significant after spin tests correction (r=0.12, p<sub>spin</sub>=0.2). Studying connectivity associations at the the local level (<italic>i.e</italic>., association between tau uptake in a region and the connectivity strength of its immediate neighbors), there were moderate associations between regional tau SUVR and both structural (r=0.53, p<sub>spin</sub>&lt;0.001) and functional connectivity patterns (r=0.46, p<sub>spin</sub>=0.06).</p></sec><sec id="S5"><title>Association with demographic, clinical, and cognitive measures</title><p id="P11">A weak and non-significant correlation was observed between age and mean MK-6240 SUVR (r = 0.23, p = 0.16, <xref ref-type="fig" rid="F3">Figure 3A</xref>). In contrast, longer disease duration was significantly associated with higher MK-6240 SUVR in patients, indicating increased tau accumulation (r = 0.50, p = 0.03). This relationship was most evident in the contralateral temporal and temporo-occipital regions, as well as the ipsilateral precuneus. Notably, the duration association to tau remained consistent even after controlling for age.</p><p id="P12">We furthermore evaluated the relationship between MK-6240 and performance measures from selected cognitive tasks (<xref ref-type="fig" rid="F3">Figure 3B</xref>). We administered the EpiTrack battery to assess executive function <sup><xref ref-type="bibr" rid="R22">22</xref></sup>, as well as a previously validated paired associate memory paradigm to assess episodic and semantic memory <sup><xref ref-type="bibr" rid="R23">23</xref></sup>.</p><p id="P13">Cognitive performance measures revealed distinct associations with MK-6240 SUVR (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). Lower EpiTrack scores, reflecting impaired executive function, correlated with higher mean MK-6240 SUVR (r = 0.41, p = 0.01). At the vertex level, lower EpiTrack scores related to increased MK-6240 SUVR in the ipsilateral superior temporal cortex and parietal cortex (angular gyrus, somatosensory area) and in the contralateral somatosensory cortex and inferior parietal lobule. Similarly, reduced episodic memory performance showed a negative relationship with MK-6240 SUVR (r = -0.38, p = 0.02). This association was localized to similar yet more extensive areas, including the ipsilateral temporal lobe and occipital regions. In contrast, semantic memory performance did not correlate with MK-6240 SUVR (r = -0.06, p = 0.72).</p></sec></sec><sec id="S6" sec-type="discussion"><title>Discussion</title><p id="P14">This study represents the first <italic>in-vivo</italic> evidence of elevated phosphorylated tau, measured by [<sup>18</sup>F]MK-6240 PET, in young adults with TLE compared to healthy controls, and examines its association with duration of disease, episodic memory performance, and local connectivity patterns. Tau increases showed a broad, bilateral distribution, with predominant involvement of the temporal and parietal cortices. Network-level analysis revealed moderate associations between regional tau uptake and both global mean connectivity and local structural and functional connectivity patterns. Notably, we observed more marked MK-6240 uptake in patients with longer disease duration and in those with more marked impairment in episodic memory and executive function. These findings suggest that tau accumulation may contribute to the progression of TLE and cognitive decline, supporting the potential role of tau in neurodegeneration in pharmaco-resistant epilepsy <italic>in-vivo</italic>.</p><p id="P15">While so far unexplored in epilepsy research, the [<sup>18</sup>F]MK-6240 PET tracer has been repeatedly applied to map disease processes in established neurodegenerative conditions, in particular AD<sup><xref ref-type="bibr" rid="R24">24</xref>–<xref ref-type="bibr" rid="R26">26</xref></sup>. In those assessments, MK-6240 has been shown to generally describe the typical Braak pattern of pathological spread away from an entorhinal/mesiotemporal disease epicentre to involve bilateral, large scale networks <sup><xref ref-type="bibr" rid="R25">25</xref>–<xref ref-type="bibr" rid="R27">27</xref></sup>. Several assessments in AD have also shown that tau PET changes have associations with overall cognitive impairment and atrophy, both at the time of scanning <sup><xref ref-type="bibr" rid="R28">28</xref>,<xref ref-type="bibr" rid="R29">29</xref></sup> and prospectively <sup><xref ref-type="bibr" rid="R30">30</xref></sup>. These findings have been complemented with several histopathological and electron microscopic validation experiments <sup><xref ref-type="bibr" rid="R31">31</xref></sup>, suggesting that MK-6240 does scale with the overall deposition of hyperphosphorylated tau. A key strength of this study is its focus on young and middle-aged individuals—an underexplored population in tau imaging research. Despite the younger age of the cohort, we observed a robust increase in MK-6240 binding in our patients. The observed pattern of tau deposition, involving the superior and middle temporal regions, as well as parietal-occipital areas, aligns in part with earlier <italic>ex-vivo</italic> observations of increased abnormalities in the ipsilateral temporal lobe relative to the epileptogenic focus <sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R32">32</xref>–<xref ref-type="bibr" rid="R34">34</xref></sup>, and confirms recent CSF-biomarker findings suggesting increased tau in TLE <sup><xref ref-type="bibr" rid="R35">35</xref></sup>. These results provide <italic>in-vivo</italic> evidence suggesting that TLE is associated with an elevated risk of tau-associated pathophysiological processes<sup><xref ref-type="bibr" rid="R36">36</xref></sup>. Crucially, we observed robust increases in tau deposition in TLE patients relative to controls after adjusting for age and sex, with findings remaining significant after correction for multiple comparisons.</p><p id="P16">Pathological validation of PET findings through post-operative immunohistochemistry will be essential for confirming <italic>in-vivo</italic> observations moving forward. An important consideration in interpreting the findings is the structural heterogeneity of tau fibrils across different tauopathies <sup><xref ref-type="bibr" rid="R37">37</xref></sup>. Tau fibrils can adopt disease-specific conformation, which in turn influence the binding properties of tau PET tracers <sup><xref ref-type="bibr" rid="R38">38</xref></sup>. In <italic>ex-vivo</italic> studies both tau isoforms 3R and 4R were confirmed in positive cases <sup><xref ref-type="bibr" rid="R10">10</xref></sup>, yet many epilepsy cases show minimal or absent pTau. This variability suggests age-related vulnerability and the involvement of multiple, potentially distinct mechanisms <sup><xref ref-type="bibr" rid="R39">39</xref></sup>. Arguably while the observed findings most likely indicate overall increases in tau, findings may also co-localize with other processes thought to play a role in TLE, including inflammatory cascades. Several reports in TLE have shown associations between cortical atrophy patterns and microglial activation as well as other inflammatory processes <sup><xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R41">41</xref></sup>. To enhance biological specificity, further studies are needed to clarify the conformation, post-translational modifications, and PET tracer binding properties of tau aggregates in epilepsy, particularly for tracers like MK-6240.</p><p id="P17">Connectome decoding models have previously been applied to describe network effects in the expression of specific imaging phenotypes, in both neurodevelopmental and neurodegenerative conditions <sup><xref ref-type="bibr" rid="R42">42</xref>–<xref ref-type="bibr" rid="R47">47</xref></sup>. In our study, we explored global as well as local connectivity associations to patient-related MK-6240 increases. While the former approach aimed to test an overall susceptibility of highly interconnected hub regions to tauopathy, the latter assessed a more local association between tau uptake and a region’s connectivity patterns. Notably, while TLE-related increases in tau showed only marginal associations with global functional connectivity, stronger associations emerged with local connectivity patterns—both structurally and functionally. These findings suggest a subtle vulnerability of polysynaptic functional hubs, alongside a more pronounced influence of local network architecture. The selective susceptibility of highly connected cortical hubs in TLE has been described in studies of atrophy, and our findings extend this vulnerability to tau pathology<sup><xref ref-type="bibr" rid="R45">45</xref></sup>. In neurodegeneration research, local connectivity has been linked to the mechanisms of regional propagation, in which tau spreads through anatomically connected networks to affect an increasing set of brain regions <sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R49">49</xref></sup>.</p><p id="P18">We found an overall association between MK-6240 and disease duration, but not age. Disease duration was associated with a more widespread increase in MK-6240 SUVR, which may reflect tau propagation along interconnected networks rather than an age-related baseline effect <sup><xref ref-type="bibr" rid="R14">14</xref></sup>. This distinction highlights the potential role of disease progression in driving large-scale tau accumulation in TLE. This suggests an accumulation of tau pathology during the clinical course of TLE, emphasizing its potential role in TLE disease progression <sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R50">50</xref></sup>. Of note, however, while longitudinal analysis in a subgroup of patients showed slightly higher annual increases in TLE patients relative to controls, findings were not statistically significant. Increasing the sample size—with ideally longer longitudinal follow up times and an older average age of included patients—may boost sensitivity to detect progressive tau uptake in TLE in future work. In AD, prior work has reported an increase in tau misfolding depositions over periods longer than five years and in individuals older than 65 years <sup><xref ref-type="bibr" rid="R51">51</xref>,<xref ref-type="bibr" rid="R52">52</xref></sup>. Despite these limitations, our findings also demonstrated significant associations between MK-6240 uptake and poorer performance in executive function and episodic memory, which again support a potential role of phosphorylated tau in progressive dysfunction in TLE. These findings suggest a vulnerability of cognitive networks governing episodic memory and executive function to tau-related pathology in TLE. The preservation of semantic memory in our patients and the absence of a correlation with MK-6240 may, on the other hand, suggest compensatory mechanisms similar to those in AD, where episodic memory and executive function are more markedly affected than semantic memory and conceptual knowledge <sup><xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R54">54</xref>,<xref ref-type="bibr" rid="R3">3</xref></sup>.</p><p id="P19">Together, these findings suggest that elevated phosphorylated tau in young adults with TLE may represent a candidate mechanism contributing to progressive network dysfunction. As tau imaging in epilepsy advances, integrating larger, longitudinal, and multimodal datasets across diverse age ranges will be critical to clarifying disease trajectories and individual variability. Ultimately, this work lays the groundwork for a network-based molecular framework of epilepsy, which can be refined as more high-resolution <italic>in-vivo</italic> and <italic>post-mortem</italic> data become available.</p></sec><sec id="S7" sec-type="methods"><title>Methods</title><sec id="S8" sec-type="subjects"><title>Participants</title><p id="P20">We recruited 18 TLE patients (6 Females, mean±SD age=34.6±10.1 years) and 20 healthy volunteers with a similar age and sex distribution (6 Females, mean±SD age=34.6±7.6 years) between May 2018 and November 2024. Diagnosis of TLE and lateralization of seizure foci were determined by the criteria of the International League Against Epilepsy (ILAE), based on a comprehensive examination that included clinical history, neurological examination, review of medical records, video-electroencephalography (EEG) recordings, and clinical MRI. As in earlier work <sup><xref ref-type="bibr" rid="R55">55</xref></sup>, hippocampal atrophy was determined as volumes or left-right asymmetry beyond 2 standard deviations of the corresponding mean of healthy controls: 7 patients had unilateral hippocampal atrophy ipsilateral to the focus and 11 had normal hippocampal volume. No control had hippocampal atrophy according to these criteria. Mean±SD age at seizure onset was 22±13 years and mean±SD duration of epilepsy was 13±10 years. Healthy controls were recruited via advertisement; all denied a history of neurological, psychiatric, or significant medical comorbidities, including traumatic brain injury. A subgroup in both cohorts had longitudinal acquisition (10/7 patients and 7 controls) with a minimum follow up time of 12 months(median=15 months, range=12 months - 3 years).</p></sec><sec id="S9"><title>Standard PROTOCOL APPROVALS, REGISTRATIONS, AND PATIENT CONSENTS</title><p id="P21">The Ethics Committee of the Montreal Neurological Institute and Hospital (MNI) approved the study (#2018-4148). Written informed consent, including a statement for open sharing of collected research data, was obtained from all participants.</p></sec><sec id="S10"><title>Pet Image Acquisition And Processing</title><p id="P22">Tau PET scanning was performed on a Siemens high-resolution research tomograph (HRRT) at the McConnell Brain Imaging Center of the MNI, using [<sup>18</sup>F]-MK-6240 tracer<sup><xref ref-type="bibr" rid="R17">17</xref></sup>, which shows low off-target binding<sup><xref ref-type="bibr" rid="R16">16</xref></sup>. The tracer was injected intravenously, and images were acquired after 90 minutes for approximately 30 minutes. A previous validation study in our center has shown that scans 90-110 minutes post-injection may optimally balance duration and signal<sup><xref ref-type="bibr" rid="R56">56</xref></sup>. In TLE, mean injected MK-6240 activity was 244.2±25.9 MBq/L. In controls, it was 236.8±40.7 MBq/L. Images were reconstructed with an ordered subset expectation maximization algorithm. A short transmission scan (11 minutes) with a rotating Cesium137 source was used for attenuation correction and later for co-registration to participant-specific MRI data. Images underwent correction for dead time, decay, as well as random and scattered coincidences. Dynamic MK-6240 images (4 in total) were co-registered and averaged. Average MK-6240 uptake was registered with an affine transformation to processed T1-weighted MRI (T1w) data (see below, and <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 5</xref>). Next, it was partial volume corrected using a probabilistic mask of the grey matter. We calculated standardized uptake value ratio (SUVR) images using the cerebellar grey matter as a reference region<sup><xref ref-type="bibr" rid="R56">56</xref></sup>. To assess reproducibility in the mixed effects models, we additionally tested the use of the brainstem and a composite reference region <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 6</xref> <sup><xref ref-type="bibr" rid="R57">57</xref></sup>. The SUVR volume was registered to the medial cortical surface derived from T1-weighted MRI, resulting in surface-based MK-6240 maps. Surface-based MK-6240 data were blurred with a 10-mm FWHM surface-based kernel, and participant-specific data were re-sampled to the fsLR-32k template surface<sup><xref ref-type="bibr" rid="R58">58</xref></sup>.</p></sec><sec id="S11"><title>Multimodal Mri Acquisition and Processing</title><p id="P23">MRI scans were also obtained at the McConnell Brain Imaging Centre, using a 3T Siemens Magnetom Prisma-Fit scanner equipped with a 64-channel head coil. Participants underwent a T1w structural scan, followed by multi-shell diffusion weighted imaging (DWI) and resting-state functional MRI (rs-fMRI). T1w images were acquired using a 3D-MPRAGE sequence (0.8 mm isovoxels). Diffusion-weighted imaging data were collected using a multi-band accelerated 2D spin-echo EPI sequence (1.6 mm isovoxels) with three b-value shells (300, 700, 2000 s/mm<sup>2</sup>) and corresponding diffusion directions (10, 40, 90), along with phase-reversed b0 images for distortion correction. rs-fMRI scans were acquired with a 7-min multiband 2D-BOLD EPI sequence (3 mm isovoxels, TR = 600 ms), with participants instructed to keep their eyes open and fixate on a cross. For detailed parameters, see <sup><xref ref-type="bibr" rid="R59">59</xref></sup>.</p><p id="P24">Multimodal MRI data processing and feature fusion leveraged micapipe v0.2.3 (<ext-link ext-link-type="uri" xlink:href="http://micapipe.readthedocs.io">http://micapipe.readthedocs.io</ext-link>), with details described elsewhere <sup><xref ref-type="bibr" rid="R60">60</xref></sup>. In brief, T1w data were processed for intensity abnormalities, followed by automated segmentation of subcortical structures using FSL FIRST <sup><xref ref-type="bibr" rid="R53">53</xref></sup>, the generation of probabilistic tissue estimates using FSL FAST <sup><xref ref-type="bibr" rid="R61">61</xref></sup>, and cortical surface segmentations using FreeSurfer 6.0 <sup><xref ref-type="bibr" rid="R62">62</xref></sup>. Surfaces were manually quality controlled and corrected if necessary. This was complemented with structural connectome (SC) generation based on diffusion-weighted MRI data, and functional connectome (FC) generation based on rs-fMRI time series. SC generation succeeded standard diffusion MRI preprocessing, which involved motion correction, denoising, and correction for inhomogeneity and geometric distortions. Anatomically constrained tractography was performed using tissue segmentations derived from each participant’s T1w images that were co-registered to native diffusion space. Multi-shell and multi-tissue response functions were estimated, followed by constrained spherical deconvolution and intensity normalization. A tractogram with 40M streamlines was generated and refined using SIFT2 <sup><xref ref-type="bibr" rid="R63">63</xref></sup>. Connection weights are defined as the weighted streamline counts between nodes mapped to the Schaefer-200 parcellation <sup><xref ref-type="bibr" rid="R64">64</xref></sup>. A second connectome used edge length as the connection weights. Finally, both measures were combined to create a weighted structural connectome (SCw) that integrates connectivity and distance information. Functional MRI processing involved motion and distortion correction, denoising, bandpass filtering, and surface registration. fMRI time-series were then averaged within Schaefer-200 cortical parcels, and FC estimated from Fisher-R-to-Z transformed cross-correlation matrices.</p></sec><sec id="S12"><title>Statistical Analysis</title><p id="P25">Analyses were performed using BrainStat<sup><xref ref-type="bibr" rid="R65">65</xref></sup>, an open-access toolbox for brain-wide statistical analysis (<ext-link ext-link-type="uri" xlink:href="http://brainstat.readthedocs.io">http://brainstat.readthedocs.io</ext-link>). In patients, prior to analysis, cortical features were sorted into ipsilateral/contralateral relative to the seizure focus.</p><list list-type="alpha-lower" id="L1"><list-item><p id="P26"><italic>Mapping of tau uptake in TLE</italic>. We compared MK-6240 vertex-wise SUVR between individuals with TLE and healthy controls using a surface-based linear mixed effects model, controlling for age, sex, and participant as a random effect. In addition to examining between-group differences, we evaluated whether within-subject longitudinal trajectories of MK-6240 SUVR differed between patients and controls using interaction models. Statistical between-group comparisons were complemented by individualized mapping of cortical areas with a high probability of MK-6240 SUVR &gt;1.5; defined as the 95nd percentile in healthy subjects.</p></list-item><list-item><p id="P27"><italic>Network contextualization</italic>. We correlated the <italic>t</italic>-statical map from analysis a) with network metrics derived from SC and FC. Specifically, network metrics were mean connectivity and neighborhood-weighted connectivity <sup><xref ref-type="bibr" rid="R66">66</xref></sup>. To minimize confounding effects, medial wall vertices were excluded from the connectome matrices in all calculations, and spin tests were performed using 10,000 permutations to assess statistical significance while accounting for spatial autocorrelation <sup><xref ref-type="bibr" rid="R67">67</xref>,<xref ref-type="bibr" rid="R68">68</xref></sup>.</p></list-item><list-item><p id="P28"><italic>Relationship to clinical and cognitive variables</italic>. We correlated global and vertex-wise SUVR data to age and disease duration, as well as cognitive measures obtained outside of the PET scanner. Cognitive assessment included the EpiTrack, a brief 15-minute screening tool designed to detect and monitor cognitive side effects of antiepileptic drugs (AEDs) and the adverse effects of seizures in patients with epilepsy. Episodic and semantic memory were also assessed using standardized tasks: the episodic memory task involved learning and recalling object pairs across encoding and retrieval phases, while the semantic memory task required identifying conceptually related object pairs from visual prompts.<sup><xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup>. TLE patients showed lower performance on the episodic memory task (<italic>t</italic>=2.53, p=0.016), while performance did not differ from controls for the EpiTrack (<italic>t</italic>=1.73, p=0.09) and the semantic memory task (<italic>t</italic>=-0.05, p=0.96). Analyses contrived for age.</p></list-item><list-item><p id="P29"><italic>Control for multiple comparisons</italic>. Findings were corrected for multiple comparisons with random field theory, two tails for the SUVR comparison between TLE and healthy subjects (p &lt; 0.001), and one tail for the vertex-wise SUVR one direction correlation with clinical and cognitive variables (p&lt;0.05).</p></list-item></list></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Information</label><media xlink:href="EMS205621-supplement-Supplementary_Information.pdf" mimetype="application" mime-subtype="pdf" id="d26aAcEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S13"><title>Acknowledgements</title><p>We thank the McConnell Brain Imaging Centre (BIC) PET and MRI units of the MNI, and the study participants for supporting our research. RRC received support from the Fonds de la Recherche du Québec – Santé (FRQ-S), the Montreal Neurological Institute Jeanne Timmins Costello Fellowship, and the Healthy Brains, Healthy Lives – Entrepreneur Postdoc Fellowship. JR received support from the Canadian Open Neuroscience Platform (CONP) and Canadian Institutes of Health Research (CIHR). MK is supported by the Wellcome Trust (221934/Z/20/Z). LC acknowledges previous support from Brain Research UK (Award 14181). BCB acknowledges support from CIHR (FDN-154298, PJT-174995), SickKids Foundation (NI17-039), Natural Sciences and Engineering Research Council (NSERC; Discovery-1304413), Azrieli Center for Autism Research of the Montreal Neurological Institute (ACAR), BrainCanada, FRQ-S, the Helmholtz International BigBrain Analytics and Learning Laboratory (Hiball), the Canada Research Chairs Program (CRC), and the Centre of Excellence in Epilepsy at the Neuro (CEEN).</p></ack><sec id="S14" sec-type="data-availability"><title>Data Availability</title><p id="P30">All the data used in the study will be found on OSF upon publication of this work (<ext-link ext-link-type="uri" xlink:href="https://osf.io/ct3gw">https://osf.io/ct3gw</ext-link>).</p></sec><sec id="S15" sec-type="data-availability"><title>Code Availability</title><p id="P31">All processing workflow scripts and the code for analyses and statistics are openly available on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/MICA-MNI/2025_in-vivo_tauPET-mk6240_TLE">https://github.com/MICA-MNI/2025_in-vivo_tauPET-mk6240_TLE</ext-link>).</p></sec><glossary><title>Glossary</title><def-list><def-item><term>TLE</term><def><p>temporal lobe epilepsy</p></def></def-item><def-item><term>PET</term><def><p>positron emission tomography</p></def></def-item><def-item><term>MRI</term><def><p>magnetic resonance imaging</p></def></def-item><def-item><term>NI</term><def><p>neuroinflammation</p></def></def-item></def-list></glossary><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitkänen</surname><given-names>A</given-names></name><name><surname>Sutula</surname><given-names>TP</given-names></name></person-group><article-title>Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy</article-title><source>Lancet Neurol</source><year>2002</year><volume>1</volume><fpage>173</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">12849486</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galovic</surname><given-names>M</given-names></name><etal/></person-group><article-title>Progressive Cortical Thinning in Patients With Focal Epilepsy</article-title><source>JAMA Neurol</source><year>2019</year><volume>76</volume><fpage>1230</fpage><lpage>1239</lpage><pub-id pub-id-type="pmcid">PMC6604082</pub-id><pub-id pub-id-type="pmid">31260004</pub-id><pub-id pub-id-type="doi">10.1001/jamaneurol.2019.1708</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>XY</given-names></name><etal/></person-group><article-title>Review: Neurodegenerative processes in temporal lobe epilepsy with hippocampal sclerosis: Clinical, pathological and neuroimaging evidence</article-title><source>Neuropathol Appl Neurobiol</source><year>2018</year><volume>44</volume><fpage>70</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">29288503</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caciagli</surname><given-names>L</given-names></name><etal/></person-group><article-title>A meta-analysis on progressive atrophy in intractable temporal lobe epilepsy: Time is brain?</article-title><source>Neurology</source><year>2017</year><volume>89</volume><fpage>506</fpage><lpage>516</lpage><pub-id pub-id-type="pmcid">PMC5539734</pub-id><pub-id pub-id-type="pmid">28687722</pub-id><pub-id pub-id-type="doi">10.1212/WNL.0000000000004176</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>PA</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Aggarwal</surname><given-names>NT</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name></person-group><article-title>Mild cognitive impairment</article-title><source>Neurology</source><year>2006</year><volume>67</volume><fpage>441</fpage><lpage>445</lpage></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noebels</surname><given-names>J</given-names></name></person-group><article-title>A perfect storm: Converging paths of epilepsy and Alzheimer’s dementia intersect in the hippocampal formation</article-title><source>Epilepsia</source><year>2011</year><volume>52</volume><issue>Suppl 1</issue><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="pmcid">PMC3058398</pub-id><pub-id pub-id-type="pmid">21214538</pub-id><pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02909.x</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><article-title>Association of Seizure Foci and Location of Tau and Amyloid Deposition and Brain Atrophy in Patients With Alzheimer Disease and Seizures</article-title><source>Neurology</source><year>2025</year><volume>104</volume><elocation-id>e210173</elocation-id><pub-id pub-id-type="pmid">39642343</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irizarry</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Incidence of new-onset seizures in mild to moderate Alzheimer disease</article-title><source>Arch Neurol</source><year>2012</year><volume>69</volume><fpage>368</fpage><lpage>372</lpage><pub-id pub-id-type="pmcid">PMC3622046</pub-id><pub-id pub-id-type="pmid">22410444</pub-id><pub-id pub-id-type="doi">10.1001/archneurol.2011.830</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amatniek</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Incidence and predictors of seizures in patients with Alzheimer’s disease</article-title><source>Epilepsia</source><year>2006</year><volume>47</volume><fpage>867</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">16686651</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>XY</given-names></name><etal/></person-group><article-title>Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections</article-title><source>Brain</source><year>2016</year><volume>139</volume><fpage>2441</fpage><lpage>2455</lpage><pub-id pub-id-type="pmcid">PMC5926008</pub-id><pub-id pub-id-type="pmid">27497924</pub-id><pub-id pub-id-type="doi">10.1093/brain/aww187</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salemme</surname><given-names>S</given-names></name><etal/></person-group><article-title>The prognosis of mild cognitive impairment: A systematic review and meta-analysis</article-title><source>Alzheimers Dement (Amst)</source><year>2025</year><volume>17</volume><elocation-id>e70074</elocation-id><pub-id pub-id-type="pmcid">PMC11898010</pub-id><pub-id pub-id-type="pmid">40078377</pub-id><pub-id pub-id-type="doi">10.1002/dad2.70074</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canet</surname><given-names>G</given-names></name><etal/></person-group><article-title>Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways</article-title><source>Epilepsia</source><year>2022</year><volume>63</volume><fpage>919</fpage><lpage>935</lpage><pub-id pub-id-type="pmid">35224720</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>M</given-names></name><name><surname>Kenny</surname><given-names>A</given-names></name><name><surname>de Leo</surname><given-names>G</given-names></name><name><surname>Beamer</surname><given-names>EH</given-names></name><name><surname>Engel</surname><given-names>T</given-names></name></person-group><article-title>Tau Phosphorylation in a Mouse Model of Temporal Lobe Epilepsy</article-title><source>Front Aging Neurosci</source><year>2019</year><volume>11</volume><elocation-id>490080</elocation-id><pub-id pub-id-type="pmcid">PMC6861366</pub-id><pub-id pub-id-type="pmid">31780921</pub-id><pub-id pub-id-type="doi">10.3389/fnagi.2019.00308</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Thom</surname><given-names>M</given-names></name><name><surname>Koepp</surname><given-names>M</given-names></name></person-group><chapter-title>Tau protein in drug-resistant epilepsy and cognitive decline</chapter-title><source>Inflammation and Epilepsy: New Vistas</source><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc><year>2021</year><fpage>149</fpage><lpage>184</lpage></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malarte</surname><given-names>ML</given-names></name><name><surname>Nordberg</surname><given-names>A</given-names></name><name><surname>Lemoine</surname><given-names>L</given-names></name></person-group><article-title>Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases</article-title><source>Eur J Nucl Med Mol Imaging</source><year>2021</year><volume>48</volume><fpage>1093</fpage><lpage>1102</lpage><pub-id pub-id-type="pmcid">PMC8041708</pub-id><pub-id pub-id-type="pmid">32970217</pub-id><pub-id pub-id-type="doi">10.1007/s00259-020-05035-y</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguero</surname><given-names>C</given-names></name><etal/></person-group><article-title>Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue</article-title><source>Acta Neuropathologica Communications</source><year>2019</year><volume>7</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmcid">PMC6410510</pub-id><pub-id pub-id-type="pmid">30857558</pub-id><pub-id pub-id-type="doi">10.1186/s40478-019-0686-6</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopewell</surname><given-names>R</given-names></name><etal/></person-group><article-title>A simplified radiosynthesis of [F]MK-6240 for tau PET imaging</article-title><source>J Labelled Comp Radiopharm</source><year>2019</year><volume>62</volume><fpage>109</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">30426529</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowlton</surname><given-names>RC</given-names></name><etal/></person-group><article-title>In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy</article-title><source>Neurology</source><year>2001</year><volume>57</volume><fpage>1184</fpage><lpage>1190</lpage><pub-id pub-id-type="pmid">11591833</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juhász</surname><given-names>C</given-names></name><etal/></person-group><article-title>Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy</article-title><source>Neurology</source><year>1999</year><volume>53</volume><fpage>2037</fpage><lpage>2045</lpage><pub-id pub-id-type="pmid">10599778</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerestes</surname><given-names>R</given-names></name><etal/></person-group><article-title>Patterns of subregional cerebellar atrophy across epilepsy syndromes: An ENIGMA-Epilepsy study</article-title><source>Epilepsia</source><year>2024</year><volume>65</volume><fpage>1072</fpage><lpage>1091</lpage><pub-id pub-id-type="pmcid">PMC11120093</pub-id><pub-id pub-id-type="pmid">38411286</pub-id><pub-id pub-id-type="doi">10.1111/epi.17881</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>CD</given-names></name><name><surname>Haaker</surname><given-names>JG</given-names></name><name><surname>Sisodiya</surname><given-names>SM</given-names></name></person-group><article-title>Structural Brain Abnormalities in the Common Epilepsies Assessed in a Worldwide ENIGMA Study</article-title><year>2018</year><pub-id pub-id-type="pmcid">PMC5837616</pub-id><pub-id pub-id-type="pmid">29365066</pub-id><pub-id pub-id-type="doi">10.1093/brain/awx341</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>MT</given-names></name><name><surname>Helmstaedter</surname><given-names>C</given-names></name></person-group><article-title>EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy</article-title><source>Epilepsy Behav</source><year>2005</year><volume>7</volume><fpage>708</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">16266826</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabalo</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Differential reorganization of episodic and semantic memory systems in epilepsy-related mesiotemporal pathology</article-title><source>Brain</source><year>2024</year><volume>147</volume><fpage>3918</fpage><lpage>3932</lpage><pub-id pub-id-type="pmcid">PMC11531848</pub-id><pub-id pub-id-type="pmid">39054915</pub-id><pub-id pub-id-type="doi">10.1093/brain/awae197</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betthauser</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls</article-title><source>Journal of Nuclear Medicine</source><year>2019</year><volume>60</volume><fpage>93</fpage><lpage>99</lpage><pub-id pub-id-type="pmcid">PMC6354223</pub-id><pub-id pub-id-type="pmid">29777006</pub-id><pub-id pub-id-type="doi">10.2967/jnumed.118.209650</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascoal</surname><given-names>TA</given-names></name><etal/></person-group><article-title>18F-MK-6240 PET for early and late detection of neurofibrillary tangles</article-title><source>Brain</source><year>2020</year><volume>143</volume><fpage>2818</fpage><lpage>2830</lpage><pub-id pub-id-type="pmid">32671408</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreisl</surname><given-names>WC</given-names></name><etal/></person-group><article-title>Patterns of tau pathology identified with 18F-MK-6240 PET imaging</article-title><source>Alzheimer’s &amp; Dementia</source><year>2022</year><volume>18</volume><fpage>272</fpage><lpage>282</lpage><pub-id pub-id-type="pmcid">PMC8630090</pub-id><pub-id pub-id-type="pmid">34057284</pub-id><pub-id pub-id-type="doi">10.1002/alz.12384</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascoal</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages</article-title><source>Brain</source><year>2021</year><volume>144</volume><fpage>3517</fpage><lpage>3528</lpage><pub-id pub-id-type="pmcid">PMC8677534</pub-id><pub-id pub-id-type="pmid">34515754</pub-id><pub-id pub-id-type="doi">10.1093/brain/awab248</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malpetti</surname><given-names>M</given-names></name><name><surname>La Joie</surname><given-names>R</given-names></name><name><surname>Rabinovici</surname><given-names>GD</given-names></name></person-group><article-title>Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials</article-title><source>Journal of Nuclear Medicine</source><year>2022</year><volume>63</volume><fpage>830</fpage><lpage>832</lpage><pub-id pub-id-type="pmcid">PMC9157718</pub-id><pub-id pub-id-type="pmid">35649659</pub-id><pub-id pub-id-type="doi">10.2967/jnumed.121.263694</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ossenkoppele</surname><given-names>R</given-names></name><etal/></person-group><article-title>Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging</article-title><source>JAMA Neurol</source><year>2021</year><volume>78</volume><fpage>961</fpage><lpage>971</lpage><pub-id pub-id-type="pmcid">PMC8240013</pub-id><pub-id pub-id-type="pmid">34180956</pub-id><pub-id pub-id-type="doi">10.1001/jamaneurol.2021.1858</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Joie</surname><given-names>R</given-names></name><etal/></person-group><article-title>Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET</article-title><source>Sci Transl Med</source><year>2020</year><volume>12</volume><pub-id pub-id-type="pmcid">PMC7035952</pub-id><pub-id pub-id-type="pmid">31894103</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aau5732</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunach</surname><given-names>P</given-names></name><etal/></person-group><article-title>Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240</article-title><source>Nat Commun</source><year>2024</year><volume>15</volume><elocation-id>8497</elocation-id><pub-id pub-id-type="pmcid">PMC11445244</pub-id><pub-id pub-id-type="pmid">39353896</pub-id><pub-id pub-id-type="doi">10.1038/s41467-024-52265-x</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gourmaud</surname><given-names>S</given-names></name><etal/></person-group><article-title>Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy</article-title><source>Brain</source><year>2020</year><volume>143</volume><fpage>191</fpage><lpage>209</lpage><pub-id pub-id-type="pmcid">PMC6935754</pub-id><pub-id pub-id-type="pmid">31834353</pub-id><pub-id pub-id-type="doi">10.1093/brain/awz381</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Tau deposition in young adults with drug-resistant focal epilepsy</article-title><source>Epilepsia</source><year>2019</year><volume>60</volume><fpage>2398</fpage><lpage>2403</lpage><pub-id pub-id-type="pmcid">PMC6973032</pub-id><pub-id pub-id-type="pmid">31663115</pub-id><pub-id pub-id-type="doi">10.1111/epi.16375</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thom</surname><given-names>M</given-names></name><etal/></person-group><article-title>Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study</article-title><source>Brain</source><year>2011</year><volume>134</volume><fpage>2969</fpage><lpage>2981</lpage><pub-id pub-id-type="pmcid">PMC3187539</pub-id><pub-id pub-id-type="pmid">21903728</pub-id><pub-id pub-id-type="doi">10.1093/brain/awr209</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballerini</surname><given-names>A</given-names></name><etal/></person-group><article-title>Late-onset temporal lobe epilepsy: insights from brain atrophy and Alzheimer’s disease biomarkers</article-title><source>Brain</source><year>2025</year><volume>148</volume><fpage>185</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">38915268</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernasconi</surname><given-names>N</given-names></name></person-group><article-title>Is epilepsy a curable neurodegenerative disease?</article-title><source>Brain</source><year>2016</year><volume>139</volume><fpage>2336</fpage><lpage>2337</lpage><pub-id pub-id-type="pmid">27559105</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaquer-Alicea</surname><given-names>J</given-names></name><name><surname>Diamond</surname><given-names>MI</given-names></name><name><surname>Joachimiak</surname><given-names>LA</given-names></name></person-group><article-title>Tau strains shape disease</article-title><source>Acta Neuropathol</source><year>2021</year><volume>142</volume><fpage>57</fpage><lpage>71</lpage><pub-id pub-id-type="pmcid">PMC8217038</pub-id><pub-id pub-id-type="pmid">33830330</pub-id><pub-id pub-id-type="doi">10.1007/s00401-021-02301-7</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groot</surname><given-names>C</given-names></name><name><surname>Villeneuve</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Hansson</surname><given-names>O</given-names></name><name><surname>Ossenkoppele</surname><given-names>R</given-names></name></person-group><article-title>Tau PET Imaging in Neurodegenerative Disorders</article-title><source>J Nucl Med</source><year>2022</year><volume>63</volume><fpage>20S</fpage><lpage>26S</lpage><pub-id pub-id-type="pmid">35649647</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mrzyglod</surname><given-names>A</given-names></name><etal/></person-group><article-title>Patterns of phosphorylated tau accumulation in a spectrum of acquired and developmental brain lesions associated with refractory epilepsy</article-title><source>Epilepsia</source><year>2025</year><pub-id pub-id-type="pmid">40299318</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altmann</surname><given-names>A</given-names></name><etal/></person-group><article-title>A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies</article-title><source>Neuropathol Appl Neurobiol</source><year>2022</year><volume>48</volume><elocation-id>e12758</elocation-id><pub-id pub-id-type="pmcid">PMC8983060</pub-id><pub-id pub-id-type="pmid">34388852</pub-id><pub-id pub-id-type="doi">10.1111/nan.12758</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickstein</surname><given-names>LP</given-names></name><etal/></person-group><article-title>Neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein</article-title><source>Epilepsia</source><year>2019</year><volume>60</volume><fpage>1248</fpage><lpage>1254</lpage><pub-id pub-id-type="pmcid">PMC7268896</pub-id><pub-id pub-id-type="pmid">31144767</pub-id><pub-id pub-id-type="doi">10.1111/epi.15967</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeley</surname><given-names>WW</given-names></name><name><surname>Crawford</surname><given-names>RK</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Greicius</surname><given-names>MD</given-names></name></person-group><article-title>Neurodegenerative diseases target large-scale human brain networks</article-title><source>Neuron</source><year>2009</year><volume>62</volume><fpage>42</fpage><lpage>52</lpage><pub-id pub-id-type="pmcid">PMC2691647</pub-id><pub-id pub-id-type="pmid">19376066</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2009.03.024</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Gennatas</surname><given-names>ED</given-names></name><name><surname>Kramer</surname><given-names>JH</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Seeley</surname><given-names>WW</given-names></name></person-group><article-title>Predicting regional neurodegeneration from the healthy brain functional connectome</article-title><source>Neuron</source><year>2012</year><volume>73</volume><fpage>1216</fpage><lpage>1227</lpage><pub-id pub-id-type="pmcid">PMC3361461</pub-id><pub-id pub-id-type="pmid">22445348</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.004</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crossley</surname><given-names>NA</given-names></name><etal/></person-group><article-title>The hubs of the human connectome are generally implicated in the anatomy of brain disorders</article-title><source>Brain</source><year>2014</year><volume>137</volume><fpage>2382</fpage><lpage>2395</lpage><pub-id pub-id-type="pmcid">PMC4107735</pub-id><pub-id pub-id-type="pmid">25057133</pub-id><pub-id pub-id-type="doi">10.1093/brain/awu132</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larivière</surname><given-names>S</given-names></name><etal/></person-group><article-title>Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study</article-title><source>Sci Adv</source><year>2020</year><volume>6</volume><pub-id pub-id-type="pmcid">PMC7673818</pub-id><pub-id pub-id-type="pmid">33208365</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.abc6457</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royer</surname><given-names>J</given-names></name><etal/></person-group><article-title>Epilepsy and brain network hubs</article-title><source>Epilepsia</source><year>2022</year><volume>63</volume><fpage>537</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">35092011</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgiadis</surname><given-names>F</given-names></name><etal/></person-group><article-title>Connectome architecture shapes large-scale cortical alterations in schizophrenia: a worldwide ENIGMA study</article-title><source>Mol Psychiatry</source><year>2024</year><volume>29</volume><fpage>1869</fpage><lpage>1881</lpage><pub-id pub-id-type="pmcid">PMC11371638</pub-id><pub-id pub-id-type="pmid">38336840</pub-id><pub-id pub-id-type="doi">10.1038/s41380-024-02442-7</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Trans-synaptic spread of tau pathology in vivo</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><elocation-id>e31302</elocation-id><pub-id pub-id-type="pmcid">PMC3270029</pub-id><pub-id pub-id-type="pmid">22312444</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0031302</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Alafuzoff</surname><given-names>I</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>Kretzschmar</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry</article-title><source>Acta Neuropathol</source><year>2006</year><volume>112</volume><fpage>389</fpage><lpage>404</lpage><pub-id pub-id-type="pmcid">PMC3906709</pub-id><pub-id pub-id-type="pmid">16906426</pub-id><pub-id pub-id-type="doi">10.1007/s00401-006-0127-z</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sánchez</surname><given-names>MP</given-names></name><name><surname>García-Cabrero</surname><given-names>AM</given-names></name><name><surname>Sánchez-Elexpuru</surname><given-names>G</given-names></name><name><surname>Burgos</surname><given-names>DF</given-names></name><name><surname>Serratosa</surname><given-names>JM</given-names></name></person-group><article-title>Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models</article-title><source>Int J Mol Sci</source><year>2018</year><volume>19</volume><pub-id pub-id-type="pmcid">PMC5979593</pub-id><pub-id pub-id-type="pmid">29621183</pub-id><pub-id pub-id-type="doi">10.3390/ijms19041092</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Longitudinal tau accumulation and atrophy in aging and alzheimer disease</article-title><source>Ann Neurol</source><year>2019</year><volume>85</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="pmcid">PMC6579738</pub-id><pub-id pub-id-type="pmid">30597624</pub-id><pub-id pub-id-type="doi">10.1002/ana.25406</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Ge</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><collab>for Alzheimer’s Disease Neuroimaging Initiative</collab></person-group><article-title>Association of hippocampal atrophy with tau pathology of temporal regions in preclinical Alzheimer’s disease</article-title><source>J Alzheimers Dis</source><year>2025</year><elocation-id>13872877251314785</elocation-id><pub-id pub-id-type="pmid">39956951</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patenaude</surname><given-names>B</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name><name><surname>Kennedy</surname><given-names>DN</given-names></name><name><surname>Jenkinson</surname><given-names>M</given-names></name></person-group><article-title>A Bayesian model of shape and appearance for subcortical brain segmentation</article-title><source>Neuroimage</source><year>2011</year><volume>56</volume><fpage>907</fpage><lpage>922</lpage><pub-id pub-id-type="pmcid">PMC3417233</pub-id><pub-id pub-id-type="pmid">21352927</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.02.046</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><article-title>Perceptual and semantic contributions to episodic memory: evidence from semantic dementia and Alzheimer’s disease</article-title><source>Journal of Memory and Language</source><year>2002</year><volume>47</volume><fpage>197</fpage><lpage>213</lpage></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernhardt</surname><given-names>BC</given-names></name><etal/></person-group><article-title>Temporal lobe epilepsy: Hippocampal pathology modulates connectome topology and controllability</article-title><source>Neurology</source><year>2019</year><volume>92</volume><fpage>e2209</fpage><lpage>e2220</lpage><pub-id pub-id-type="pmcid">PMC6537128</pub-id><pub-id pub-id-type="pmid">31004070</pub-id><pub-id pub-id-type="doi">10.1212/WNL.0000000000007447</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascoal</surname><given-names>TA</given-names></name><etal/></person-group><article-title>In vivo quantification of neurofibrillary tangles with [F]MK-6240</article-title><source>Alzheimers Res Ther</source><year>2018</year><volume>10</volume><fpage>74</fpage><pub-id pub-id-type="pmcid">PMC6069775</pub-id><pub-id pub-id-type="pmid">30064520</pub-id><pub-id pub-id-type="doi">10.1186/s13195-018-0402-y</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landau</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios</article-title><source>J Nucl Med</source><year>2015</year><volume>56</volume><fpage>567</fpage><lpage>574</lpage><pub-id pub-id-type="pmcid">PMC5313473</pub-id><pub-id pub-id-type="pmid">25745095</pub-id><pub-id pub-id-type="doi">10.2967/jnumed.114.148981</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Essen</surname><given-names>DC</given-names></name><name><surname>Glasser</surname><given-names>MF</given-names></name><name><surname>Dierker</surname><given-names>DL</given-names></name><name><surname>Harwell</surname><given-names>J</given-names></name><name><surname>Coalson</surname><given-names>T</given-names></name></person-group><article-title>Parcellations and hemispheric asymmetries of human cerebral cortex analyzed on surface-based atlases</article-title><source>Cereb Cortex</source><year>2012</year><volume>22</volume><fpage>2241</fpage><lpage>2262</lpage><pub-id pub-id-type="pmcid">PMC3432236</pub-id><pub-id pub-id-type="pmid">22047963</pub-id><pub-id pub-id-type="doi">10.1093/cercor/bhr291</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royer</surname><given-names>J</given-names></name><etal/></person-group><article-title>An Open MRI Dataset For Multiscale Neuroscience</article-title><source>Sci Data</source><year>2022</year><volume>9</volume><fpage>569</fpage><pub-id pub-id-type="pmcid">PMC9477866</pub-id><pub-id pub-id-type="pmid">36109562</pub-id><pub-id pub-id-type="doi">10.1038/s41597-022-01682-y</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruces</surname><given-names>RR</given-names></name><etal/></person-group><article-title>Micapipe: A pipeline for multimodal neuroimaging and connectome analysis</article-title><source>Neuroimage</source><year>2022</year><volume>263</volume><elocation-id>119612</elocation-id><pub-id pub-id-type="pmcid">PMC10697132</pub-id><pub-id pub-id-type="pmid">36070839</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2022.119612</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Brady</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name></person-group><article-title>Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm</article-title><source>IEEE Trans Med Imaging</source><year>2001</year><volume>20</volume><fpage>45</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">11293691</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischl</surname><given-names>B</given-names></name></person-group><article-title>FreeSurfer</article-title><source>Neuroimage</source><year>2012</year><volume>62</volume><fpage>774</fpage><lpage>781</lpage><pub-id pub-id-type="pmcid">PMC3685476</pub-id><pub-id pub-id-type="pmid">22248573</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.01.021</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tournier</surname><given-names>JD</given-names></name><etal/></person-group><article-title>MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation</article-title><source>Neuroimage</source><year>2019</year><volume>202</volume><elocation-id>116137</elocation-id><pub-id pub-id-type="pmid">31473352</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Local-Global Parcellation of the Human Cerebral Cortex from Intrinsic Functional Connectivity MRI</article-title><source>Cereb Cortex</source><year>2018</year><volume>28</volume><fpage>3095</fpage><lpage>3114</lpage><pub-id pub-id-type="pmcid">PMC6095216</pub-id><pub-id pub-id-type="pmid">28981612</pub-id><pub-id pub-id-type="doi">10.1093/cercor/bhx179</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larivière</surname><given-names>S</given-names></name><etal/></person-group><article-title>BrainStat: A toolbox for brain-wide statistics and multimodal feature associations</article-title><source>Neuroimage</source><year>2023</year><volume>266</volume><elocation-id>119807</elocation-id><pub-id pub-id-type="pmcid">PMC10715099</pub-id><pub-id pub-id-type="pmid">36513290</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2022.119807</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafiei</surname><given-names>G</given-names></name><etal/></person-group><article-title>Spatial Patterning of Tissue Volume Loss in Schizophrenia Reflects Brain Network Architecture</article-title><source>Biol Psychiatry</source><year>2020</year><volume>87</volume><fpage>727</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">31837746</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vos de Wael</surname><given-names>R</given-names></name><etal/></person-group><article-title>BrainSpace: a toolbox for the analysis of macroscale gradients in neuroimaging and connectomics datasets</article-title><source>Commun Biol</source><year>2020</year><volume>3</volume><fpage>103</fpage><pub-id pub-id-type="pmcid">PMC7058611</pub-id><pub-id pub-id-type="pmid">32139786</pub-id><pub-id pub-id-type="doi">10.1038/s42003-020-0794-7</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander-Bloch</surname><given-names>AF</given-names></name><etal/></person-group><article-title>On testing for spatial correspondence between maps of human brain structure and function</article-title><source>Neuroimage</source><year>2018</year><volume>178</volume><fpage>540</fpage><lpage>551</lpage><pub-id pub-id-type="pmcid">PMC6095687</pub-id><pub-id pub-id-type="pmid">29860082</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2018.05.070</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>A) Group-Wise mean tau MK-6240 uptake</bold>. Cortical and subcortical phosphorylated tau deposits were assessed with MK-6240 and visualized as standardized uptake value ratios (SUVR). The average MK-6240 uptake is shown for healthy controls and TLE patients. <bold>B) Group differences in MK-6240 uptake</bold>. Group comparisons between patients and controls were performed using a mixed-effects model, adjusting for age and sex, and corrected for multiple comparisons using random field theory (p &lt; 0.001). Significant regions are outlined in white. Violin plots display mean SUVR values for significant regions in each hemisphere by group, with differences assessed using a two-tailed Wilcoxon rank-sum test. <bold>C) Subject-Wise Distribution of Cortical MK-6240 Uptake</bold>. Density histograms illustrate the distribution of global cortical MK-6240 uptake for individual subjects in each group. Red squares indicate regions where SUVR exceeds the abnormality threshold (SUVR &gt; 1.5). Brain images represent individual subjects from each group with progressively increasing MK-6240 values.</p></caption><graphic xlink:href="EMS205621-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>A)</bold> <italic>Relationship between MK-6240 group differences and functional connectivity</italic>. The left panel displays a scatterplot of mean node values from the functional connectome against tau MK-6240 group differences (r = 0.39, p-value =0.19). The right panel visualizes neighboring regions of each node determined by functional connectivity, with their association to tau MK-6240 group differences (r = 0.47, p-value =0.05). <bold>B)</bold> <italic>Relationship between MK-6240 group differences and structural connectivity</italic>. The structural connectome was derived from diffusion MRI tractography, and we studied its association with MK-6240 group differences. The left panel shows a logarithmic scatter plot of mean node values against group differences (r = 0.13, p-value =0.20). The right panel highlights neighboring regions based on structural connectivity, which show a strong trend of increased tau deposition (r = 0.55, p-value &lt;0.001). The central image depicts how functional (<italic>upper</italic>) and structural (<italic>lower</italic>) connectivity informed by MK-6240 group differences was used to generate neighbor-weighted MK-6240 estimates. Points are color-coded based on MK-6240 t-values, with higher t-values indicating greater tau deposits in TLE compared to controls. The red line represents non-linear trends in the data. These findings suggest that both functional and structural network properties significantly reflected the spatial distribution of MK-6240 increases in TLE, with network hubs and their connected regions being particularly vulnerable.</p></caption><graphic xlink:href="EMS205621-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>A)</bold> <italic>Tau MK-6240 SUVR and clinical relationships</italic>. Scatterplots show the association of mean MK-6240 SUVR with clinical variables. The top panel shows the relationship with age (r = 0.23, p-value = 0.16), and the bottom panel illustrates the association with disease duration (r = 0.5, p-value = 0.03). Corresponding cortical projections visualize the regional effects of these variables on MK-6240 SUVR. Dark red on the brain maps indicate regions where age and duration are associated with increased tau deposition, as measured by t-statistics. <bold>B)</bold> <italic>Tau MK-6240 SUVR and behavioral relationships</italic>. Scatterplots display the relationship of mean MK-6240 SUVR with behavioral measures. The top panel shows the association with EpiTrack scores (r = 0.41, p-value = 0.01), the middle panel with episodic memory z-scores (r = -0.38, p-value = 0.02), and the bottom panel with semantic memory z-scores (r = -0.06, p-value = 0.72). Brain maps illustrate the corresponding regional effects, dark blue indicating areas where lower cognitive performance is associated with higher MK-6240 SUVR. Mixed-effects models were applied to assess the association between MK-6240 SUVR and these features, corrected for multiple comparisons with random field theory (p&lt;0.01, one tail). Only significant values are highlighted; the rest are set to an alpha value of 0.2.</p></caption><graphic xlink:href="EMS205621-f003"/></fig></floats-group></article>